Jump to main content
Jump to site search
PLANNED MAINTENANCE Close the message box

Scheduled maintenance upgrade on Thursday 4th of May 2017 from 8.00am to 9.00am (BST).

During this time our websites will be offline temporarily. If you have any questions please use the feedback button on this page. We apologise for any inconvenience this might cause and thank you for your patience.


Issue 4, 2013
Previous Article Next Article

Peptide B12: emerging trends at the interface of inorganic chemistry, chemical biology and medicine

Author affiliations

Abstract

The sophisticated and efficient delivery of vitamin B12 (“B12”) into cells offers promise for B12-bioconjugates in medicinal diagnosis and therapy. It is therefore surprising that rather little attention is presently paid to an alternative strategy in drug design: the development of structurally perfect, but catalytically inactive semi-artificial B12 surrogates. Vitamin B12 cofactors catalyse important biological transformations and are indispensible for humans and most other forms of life. This strong metabolic dependency exhibits enormous medicinal opportunities. Inhibitors of B12 dependent enzymes are potential suppressors of fast proliferating cancer cells. This perspective article focuses on the design and study of backbone modified B12 derivatives, particularly on peptide B12 derivatives. Peptide B12 is a recently introduced class of biomimetic cobalamins bearing an artificial peptide backbone with adjustable coordination and redox-properties. Pioneering biological studies demonstrated reduced catalytic activity, combined with inhibitory potential that is encouraging for future efforts in turning natural cofactors into new anti-proliferative agents.

Graphical abstract: Peptide B12: emerging trends at the interface of inorganic chemistry, chemical biology and medicine

Back to tab navigation
Please wait while Download options loads

Publication details

The article was received on 31 Aug 2012, accepted on 30 Oct 2012 and first published on 19 Nov 2012


Article type: Perspective
DOI: 10.1039/C2DT32005C
Citation: Dalton Trans., 2013,42, 854-862
  •   Request permissions

    Peptide B12: emerging trends at the interface of inorganic chemistry, chemical biology and medicine

    F. Zelder, K. Zhou and M. Sonnay, Dalton Trans., 2013, 42, 854
    DOI: 10.1039/C2DT32005C

Search articles by author